CDY 1.43% 7.1¢ cellmid limited

Ann: Cellmid to Commence Selling of Evolis into Chinese Market, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 356 Posts.
    lightbulb Created with Sketch. 56
    Technical commissioning service
    Technology commissioned R&D services can be provided to complete the entire process of R&D, R&D, pilot, and large-scale production.

    Registration consulting
    Provide domestic and foreign companies with registration and market access services for pharmaceuticals, health products and medical devices in mainland China.

    Production and processing
    The company has a pharmaceutical factory and a raw material pharmaceutical factory in Foshan and Liaoyuan. It can provide solid preparations, tablet raw materials and intermediates,
    etc.

    GMP plant construction
    Including assisting in the construction of GMP plant, training of GMP standard personnel.

    Clinical research
    He has rich clinical research experience in China, including 1-4 clinical studies.

    commercialize
    Has a strong sales team in the country.
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.